Second-line efficacy of intermediate high-dose methotrexate with citrovorum factor rescue + cyclophosphamide in ovarian cancer
- 1 April 1979
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 7 (2), 233-238
- https://doi.org/10.1016/0090-8258(79)90099-4
Abstract
No abstract availableThis publication has 4 references indexed in Scilit:
- Second trial drugs in ovarian cancerGynecologic Oncology, 1977
- SINGLE AGENT VS COMBINATION CHEMOTHERAPY IN TREATMENT OF OVARIAN CANCER1977
- METHOTREXATE (NSC-740) WITH CITROVORUM FACTOR (NSC-3590) RESCUE, ALONE AND IN COMBINATION WITH CYCLOPHOSPHAMIDE (NSC-26271), IN OVARIAN CANCER1976
- PHASE-2 STUDY OF CIS-DICHLORODIAMMINEPLATINUM(II) (NSC-119875) IN ADVANCED ADENOCARCINOMA OF OVARY1976